Skip to main content
OpenTrials

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

9,958 public trials 2,018 recruiting studies
Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Recruiting

International Study for Treatment of High Risk Childhood Relapsed ALL 2010

NCT03590171

Conditions
Acute Lymphoblastic Leukemia (ALL), Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations
  • Australian & New Zealand Childhood Hematology & Oncology Group Clayton, Victoria, Australia
  • St. Anna Kinderkrebsforschung, CCRI Vienna, Austria
  • Hòpital Universitaire des Enfants Reine Fabiola Brussels, Belgium
  • University Hospital Motol Prague, Czechia
View all 15 locations
View Trial Details
Recruiting

Asparaginase Erwinia Chrysanthemi With Chemotherapy for the Treatment of High-Risk Adults With Newly Diagnosed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma

NCT06918431

Conditions
B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative, Burkitt Lymphoma, DNA Virus Infections, +20 more
Locations
  • City of Hope at Phoenix Phoenix, Arizona, United States
  • City of Hope Medical Center Duarte, California, United States
  • City of Hope at Irvine Lennar Irvine, California, United States
  • UC San Diego Moores Cancer Center La Jolla, California, United States
View Trial Details
Recruiting

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

NCT06418204

Conditions
Breast Carcinoma, Breast Diseases, Breast Neoplasms, +39 more
Locations
  • Fairbanks Memorial Hospital Fairbanks, Alaska, United States
  • Kingman Regional Medical Center Kingman, Arizona, United States
  • Cancer Center at Saint Joseph's Phoenix, Arizona, United States
  • Mercy Hospital Fort Smith Fort Smith, Arkansas, United States
View all 467 locations
View Trial Details
Recruiting

A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation

NCT06859424

Conditions
AML (Acute Myelogenous Leukemia), Acute Leukemia (Category), Acute Lymphoid Leukemia (ALL), +36 more
Locations
  • University of Alabama Birmingham Birmingham, Alabama, United States
  • City of Hope Duarte, California, United States
  • Stanford Palo Alto, California, United States
  • University of Miami Miami, Florida, United States
View all 13 locations
View Trial Details

Related conditions